GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (AQSE:HCM.GB) » Definitions » Buildings And Improvements

HUTCHMED (China) (AQSE:HCM.GB) Buildings And Improvements : £0.0 Mil (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is HUTCHMED (China) Buildings And Improvements?

HUTCHMED (China)'s quarterly buildings and improvements increased from Jun. 2023 (£0.0 Mil) to Dec. 2023 (£62.5 Mil) but then declined from Dec. 2023 (£62.5 Mil) to Jun. 2024 (£0.0 Mil).

HUTCHMED (China)'s annual buildings and improvements declined from Dec. 2021 (£24.0 Mil) to Dec. 2022 (£22.7 Mil) but then increased from Dec. 2022 (£22.7 Mil) to Dec. 2023 (£62.5 Mil).


HUTCHMED (China) Buildings And Improvements Historical Data

The historical data trend for HUTCHMED (China)'s Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HUTCHMED (China) Buildings And Improvements Chart

HUTCHMED (China) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.76 14.78 23.95 22.65 62.47

HUTCHMED (China) Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 22.65 - 62.47 -

HUTCHMED (China) Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.


HUTCHMED (China) Business Description

Address
2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

HUTCHMED (China) Headlines

No Headlines